On January 22, 2020, pursuant to terms of that certain Stockholders Agreement, originally entered into by GNC Holdings, Inc. as of November 7, 2018 (the Stockholders Agreement"), the company's Board of Directors, upon designation by Harbin Pharmaceutical Group Co. Ltd., and based on the recommendation of the Board's Nominating and Corporate Governance Committee, appointed each of Rachel Lau and Alan Wan to the Board, effective January 22, 2020. Since 2017, Ms. Lau has served as Co-Founder and Managing Partner of RHL Ventures. Since 2014, Mr. Wan has served as Founder and Chairman of the PINS Capital Group.